EFFICACY AND SAFETY OF TOCILIZUMAB IN CHILDREN WITH SYSTEMIC JUVENILE ARTHRITIS IN CLINICAL PRACTICE

The paper presents the results of a prospective trial of the efficiency and safety of tocilizumab (TCZ) therapy for sys- temic juvenile arthritis. It analyzes the impact of factors, such as age at onset of the disease, its duration at the time of TCZ therapy initiation,  the number of systemic manif...

Full description

Bibliographic Details
Main Authors: M. I. Kaleda, I. P. Nikishina
Format: Article
Language:Russian
Published: IMA PRESS LLC 2015-04-01
Series:Научно-практическая ревматология
Subjects:
Online Access:https://rsp.mediar-press.net/rsp/article/view/2077
_version_ 1797862735534358528
author M. I. Kaleda
I. P. Nikishina
author_facet M. I. Kaleda
I. P. Nikishina
author_sort M. I. Kaleda
collection DOAJ
description The paper presents the results of a prospective trial of the efficiency and safety of tocilizumab (TCZ) therapy for sys- temic juvenile arthritis. It analyzes the impact of factors, such as age at onset of the disease, its duration at the time of TCZ therapy initiation,  the number of systemic manifestations, activity of arthritis, and previous experience in using other biological agents, on the efficiency of the therapy. Moreover, the safety of long-term  TCZ usage, reasons for dis- continuation of the therapy, its resumption  possibilities, and ways of enhancing  therapeutic  effectiveness are analyzed.
first_indexed 2024-04-09T22:25:23Z
format Article
id doaj.art-98d66b3619a24bfea7d7730979618625
institution Directory Open Access Journal
issn 1995-4484
1995-4492
language Russian
last_indexed 2024-04-09T22:25:23Z
publishDate 2015-04-01
publisher IMA PRESS LLC
record_format Article
series Научно-практическая ревматология
spelling doaj.art-98d66b3619a24bfea7d77309796186252023-03-22T13:45:50ZrusIMA PRESS LLCНаучно-практическая ревматология1995-44841995-44922015-04-0153220421310.14412/1995-4484-2015-204-2131967EFFICACY AND SAFETY OF TOCILIZUMAB IN CHILDREN WITH SYSTEMIC JUVENILE ARTHRITIS IN CLINICAL PRACTICEM. I. Kaleda0I. P. Nikishina1V.A. Nasonova Research Institute of Rheumatology, MoscowV.A. Nasonova Research Institute of Rheumatology, MoscowThe paper presents the results of a prospective trial of the efficiency and safety of tocilizumab (TCZ) therapy for sys- temic juvenile arthritis. It analyzes the impact of factors, such as age at onset of the disease, its duration at the time of TCZ therapy initiation,  the number of systemic manifestations, activity of arthritis, and previous experience in using other biological agents, on the efficiency of the therapy. Moreover, the safety of long-term  TCZ usage, reasons for dis- continuation of the therapy, its resumption  possibilities, and ways of enhancing  therapeutic  effectiveness are analyzed.https://rsp.mediar-press.net/rsp/article/view/2077systemic juvenile arthritistocilizumabefficacysafety
spellingShingle M. I. Kaleda
I. P. Nikishina
EFFICACY AND SAFETY OF TOCILIZUMAB IN CHILDREN WITH SYSTEMIC JUVENILE ARTHRITIS IN CLINICAL PRACTICE
Научно-практическая ревматология
systemic juvenile arthritis
tocilizumab
efficacy
safety
title EFFICACY AND SAFETY OF TOCILIZUMAB IN CHILDREN WITH SYSTEMIC JUVENILE ARTHRITIS IN CLINICAL PRACTICE
title_full EFFICACY AND SAFETY OF TOCILIZUMAB IN CHILDREN WITH SYSTEMIC JUVENILE ARTHRITIS IN CLINICAL PRACTICE
title_fullStr EFFICACY AND SAFETY OF TOCILIZUMAB IN CHILDREN WITH SYSTEMIC JUVENILE ARTHRITIS IN CLINICAL PRACTICE
title_full_unstemmed EFFICACY AND SAFETY OF TOCILIZUMAB IN CHILDREN WITH SYSTEMIC JUVENILE ARTHRITIS IN CLINICAL PRACTICE
title_short EFFICACY AND SAFETY OF TOCILIZUMAB IN CHILDREN WITH SYSTEMIC JUVENILE ARTHRITIS IN CLINICAL PRACTICE
title_sort efficacy and safety of tocilizumab in children with systemic juvenile arthritis in clinical practice
topic systemic juvenile arthritis
tocilizumab
efficacy
safety
url https://rsp.mediar-press.net/rsp/article/view/2077
work_keys_str_mv AT mikaleda efficacyandsafetyoftocilizumabinchildrenwithsystemicjuvenilearthritisinclinicalpractice
AT ipnikishina efficacyandsafetyoftocilizumabinchildrenwithsystemicjuvenilearthritisinclinicalpractice